Biogen (BIIB) Other financing activities (2009 - 2026)

Biogen (BIIB) has reported Other financing activities for 18 consecutive years, with $11.3 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Other financing activities rose 769.23% year-over-year to $11.3 million; the TTM figure through Mar 2026 stood at $15.0 million (up 350.0% YoY), while the FY2025 annual figure was $5.0 million, changed N/A from the prior year.
• Other financing activities came in at $11.3 million for Q1 2026 at Biogen, up from -$1.3 million in the prior quarter.
• The five-year high for Other financing activities was $11.3 million in Q1 2026, with the low at -$17.8 million in Q4 2022.
• Average Other financing activities over 5 years is $276470.6, with a median of $1.3 million recorded in 2025.
• The largest YoY upside for Other financing activities was 3550.0% in 2024 against a maximum downside of 604.0% in 2024.
• Year by year, Other financing activities stood at -$17.8 million in 2022, then surged by 42.7% to -$10.2 million in 2023, then surged by 164.71% to $6.6 million in 2024, then slumped by 119.7% to -$1.3 million in 2025, then surged by 969.23% to $11.3 million in 2026.
• According to Business Quant data, Other financing activities over the past three periods registered $11.3 million, -$1.3 million, and $6.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.